Biochemistry Quiz: Glycogen Metabolism

What this quiz covers

This quiz focuses on Glycogen Metabolism, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. The conversion of G1P to G6P by phosphoglucomutase generates one molecule of ATP via substrate-level phosphorylation.
2. It bypasses the hexokinase reaction, which is the main irreversible, rate-limiting step of the entire glycolytic pathway.
3. It saves one molecule of ATP per glucose unit, resulting in a net yield of three ATP from anaerobic glycolysis instead of two. (correct answer)
4. It generates UDP during the breakdown process, which allosterically activates phosphofructokinase-1 (PFK-1).

Explanation: Free glucose entering a cell must be phosphorylated to glucose-6-phosphate by hexokinase, a reaction that consumes one ATP. When starting from glycogen, the glucose unit is released as G1P and converted to G6P, bypassing the hexokinase step. This means the 'investment' phase of glycolysis only costs one ATP (at the PFK-1 step) instead of two. Therefore, the net gain from anaerobic glycolysis is 3 ATP per glucose unit from glycogen, versus 2 ATP from free blood glucose.

Question 2

1. High AMP levels allosterically activate the already active, phosphorylated form (phosphorylase a).
2. High ATP levels inhibit the dephosphorylated form (phosphorylase b), an effect that dominates during intense activity.
3. High AMP levels allosterically activate the typically inactive, dephosphorylated form (phosphorylase b), promoting rapid glycogenolysis. (correct answer)
4. High AMP levels inhibit glycogen synthase, which indirectly causes a feedback activation of glycogen phosphorylase.

Explanation: In muscle, the dephosphorylated, typically less active form of glycogen phosphorylase (phosphorylase b) can be allosterically activated by high levels of AMP. This allows the muscle to rapidly mobilize glucose from glycogen in response to an immediate energy demand (low ATP/high AMP), even before hormonal signals (like epinephrine) have had time to cause its phosphorylation to the more active 'a' form.

Question 3

1. Insulin-stimulated activation of protein phosphatase 1 (PP1), which dephosphorylates glycogen synthase.
2. Inactivation of glycogen phosphorylase 'a', which relieves its inhibitory effect on the phosphatase that acts on glycogen synthase.
3. Allosteric activation of glycogen synthase by elevated intracellular concentrations of glucose-6-phosphate.
4. Suppression of fatty acid oxidation due to high levels of malonyl-CoA inhibiting carnitine acyltransferase I. (correct answer)

Explanation: Choices A, B, and C are all direct molecular mechanisms that increase the activity of glycogen synthase. (A) Insulin activates PP1, which directly dephosphorylates and activates the synthase. (C) High glucose influx leads to high G6P, a key allosteric activator. (B) Active phosphorylase 'a' inhibits PP1; inactivating phosphorylase removes this inhibition. In contrast, (D) describes the inhibition of beta-oxidation. While this is a critical part of the overall fed-state metabolic program (shifting from fat burning to fat/glycogen storage), it does not directly regulate the activity of the glycogen synthase enzyme itself.

Question 4

1. A rapid increase in blood glucose levels due to a strong compensatory activation of gluconeogenesis.
2. A significant increase in muscle glycogenolysis to compensate for the lack of liver glucose output.
3. An increase in the rate of glycogen synthesis in the liver as glucose-1-phosphate accumulates from the inhibited pathway.
4. A decrease in the rate of glucose release from the liver, potentially leading to hypoglycemia. (correct answer)

Explanation: When you encounter questions about enzyme inhibition during metabolic states like fasting, focus on the primary metabolic pathway being affected and the immediate consequences before compensatory mechanisms kick in. Glycogen phosphorylase 'a' is the active form of the key enzyme that breaks down liver glycogen into glucose during fasting. This process, called glycogenolysis, is essential for maintaining blood glucose levels when you're not eating. The liver acts as the body's glucose buffer, releasing stored glucose to keep blood sugar stable. If an allosteric inhibitor blocks this enzyme, glycogenolysis in the liver essentially stops. Since the liver can no longer break down its glycogen stores to release glucose into the bloodstream, glucose output from the liver drops dramatically. During fasting, when the body depends heavily on this hepatic glucose release, this reduction would likely cause blood glucose levels to fall, potentially leading to hypoglycemia. This makes option D correct. Option A is wrong because while gluconeogenesis might eventually compensate, it's a slower process and wouldn't immediately prevent the drop in glucose from halted glycogenolysis. Option B incorrectly assumes muscle glycogenolysis significantly contributes to blood glucose—muscle primarily uses its glycogen stores for its own energy needs. Option C misunderstands the pathway: inhibiting glycogen phosphorylase would actually decrease glucose-1-phosphate production, not increase it, since this enzyme is what produces glucose-1-phosphate from glycogen. Remember: always consider the immediate, direct effects of enzyme inhibition before thinking about compensatory mechanisms, which take time to activate.

Question 5

1. One ATP equivalent, from the conversion of UTP to UDP.
2. Two ATP equivalents, due to the hydrolysis of both UTP and pyrophosphate. (correct answer)
3. Zero ATP equivalents, as the process is driven by concentration gradients.
4. Three ATP equivalents, including the ATP required to regenerate UTP.

Explanation: The reaction catalyzed by UDP-glucose pyrophosphorylase is: G1P + UTP ⇌ UDP-glucose + PPi. This consumes one high-energy bond. The pyrophosphate (PPi) is rapidly hydrolyzed by pyrophosphatase to 2 Pi, an exergonic reaction that consumes a second high-energy phosphate bond equivalent. This hydrolysis makes the overall process of UDP-glucose formation irreversible and costs a total of two ATP equivalents.

Question 6

1. In both tissues, the goal is to release free glucose into the bloodstream to supply the brain and other vital organs with energy.
2. In liver, the goal is to maintain blood glucose homeostasis by exporting free glucose; in muscle, the goal is to provide fuel for glycolysis within that same muscle cell. (correct answer)
3. In muscle, epinephrine triggers glycogenolysis for export to the liver, while in the liver, it triggers glycogenolysis for immediate internal ATP production.
4. Epinephrine stimulates glycogenolysis in muscle but stimulates glycogen synthesis in the liver to prepare for subsequent recovery from stress.

Explanation: This question highlights the tissue-specific roles of glycogen. The liver's primary role is to maintain blood glucose levels; it contains glucose-6-phosphatase, which allows it to convert the product of glycogenolysis into free glucose for export. Muscle lacks this enzyme. Therefore, when muscle breaks down its glycogen stores, the resulting glucose-6-phosphate is trapped within the cell and used directly for its own energy needs via glycolysis.

Question 7

1. 1:1, because every glucose released from the polymer requires both enzymes acting in concert.
2. 2:1, reflecting the two distinct catalytic activities of the debranching enzyme complex.
3. Approximately 10:1, because branch points occur on average every 10 to 12 glucose residues. (correct answer)
4. 100:1, because glycogen molecules are extremely large with relatively few branch points for stability.

Explanation: Glycogen phosphorylase removes glucose units from the non-reducing ends of chains, producing glucose-1-phosphate. It can act on all residues except those near a branch point. The debranching enzyme releases a single molecule of free glucose from each α-1,6 branch point. Since branch points occur roughly every 10-12 residues, for every one free glucose released, approximately 9-11 molecules of glucose-1-phosphate will have been released by phosphorylase. Thus, the ratio is about 10:1.

Question 8

1. The glucagon signal would be amplified, leading to a much faster and more complete glycogenolysis than normal.
2. The cell would be locked in a state of glycogen synthesis, as PP1 would be constitutively active regardless of hormonal signals.
3. Glycogen synthesis and breakdown would become completely unresponsive to glucagon signaling due to a futile cycle.
4. The glucagon signal would be dampened, as PP1 would remain active and oppose the actions of phosphorylase kinase. (correct answer)

Explanation: When analyzing glycogen metabolism questions, focus on the opposing regulatory mechanisms that control synthesis versus breakdown, and how hormonal signals coordinate these pathways through phosphorylation cascades. Let's trace through the normal glucagon signaling pathway: Glucagon activates PKA, which phosphorylates multiple targets to promote glycogen breakdown. One key target is the PP1 inhibitor subunit. When PKA phosphorylates this inhibitor, it binds to and inactivates PP1. Since PP1 normally promotes glycogen synthesis by dephosphorylating (activating) glycogen synthase and dephosphorylating (inactivating) phosphorylase kinase, shutting down PP1 is essential for effective glycogenolysis. With the mutation preventing inhibitor phosphorylation, PP1 remains active even when glucagon signals for glycogen breakdown. Active PP1 continues dephosphorylating phosphorylase kinase (inactivating it) and maintaining glycogen synthase in its active state. This creates a situation where the glucagon signal is significantly weakened because PP1 actively opposes the phosphorylation events that PKA is trying to establish. Answer choice A incorrectly suggests signal amplification when the opposite occurs. Choice B is wrong because the cell isn't locked in synthesis mode - PKA can still phosphorylate other targets, just not effectively. Choice C misrepresents the situation as complete unresponsiveness rather than dampened signaling. The correct answer is D - the glucagon response is dampened because constitutively active PP1 works against PKA's phosphorylation efforts. Study tip: For glycogen regulation questions, always map out which enzymes are active/inactive in each metabolic state and identify the phosphatases and kinases controlling those switches.

Question 9

1. De novo synthesis of new glycogen molecules cannot occur, although breakdown of existing molecules is unaffected. (correct answer)
2. Pre-existing glycogen molecules can be broken down but can no longer be elongated by glycogen synthase.
3. The rate of glycogen synthesis is significantly reduced, as glycogen synthase must now self-prime at a very low efficiency.
4. The branching of glycogen molecules is inhibited, leading to the formation of long, amylose-like chains.

Explanation: When you encounter questions about glycogen metabolism, focus on the sequential steps required for synthesis and how each enzyme has a specific role that cannot be substituted by others. Glycogenin is essential for initiating glycogen synthesis because it serves dual functions: acting as a protein primer and catalyzing the formation of the first 8-10 glucose residues through its glucosyltransferase activity. Without functional glucosyltransferase activity, glycogenin cannot create the initial glucose chain that glycogen synthase requires to begin elongation. Since glycogen synthase can only add glucose residues to existing chains (it cannot start synthesis de novo), the complete loss of glycogenin's catalytic function prevents any new glycogen molecules from forming. However, existing glycogen molecules remain structurally intact and can still be broken down by glycogen phosphorylase, which works independently of glycogenin. Answer A correctly identifies this fundamental requirement - new glycogen synthesis is impossible without functional glycogenin, while breakdown remains unaffected. Answer B incorrectly suggests existing glycogen can't be elongated; glycogen synthase can still extend pre-existing molecules. Answer C is wrong because glycogen synthase cannot self-prime at any efficiency - it absolutely requires an existing glucose chain. Answer D confuses glycogenin's role with that of the branching enzyme; glycogenin doesn't affect branching patterns. Remember that glycogen synthesis requires a strict sequence: glycogenin creates the primer, glycogen synthase elongates it, and branching enzyme adds branches. Each step depends on the previous one, so identify which specific step is disrupted in the question.

Question 10

1. Glycogen synthase is phosphorylated and inactive; glycogen phosphorylase is phosphorylated and active. (correct answer)
2. Glycogen synthase is dephosphorylated and active; glycogen phosphorylase is dephosphorylated and inactive.
3. Both enzymes are phosphorylated, which leads to the simultaneous inhibition of both glycogen synthesis and breakdown.
4. Both enzymes are dephosphorylated, which leads to the simultaneous activation of both glycogen synthesis and breakdown.

Explanation: During fasting, glucagon signaling activates Protein Kinase A (PKA). PKA phosphorylates and inactivates glycogen synthase. PKA also initiates a cascade that phosphorylates and activates glycogen phosphorylase. This ensures that glycogen synthesis is turned off and glycogen breakdown is turned on to release glucose into the blood.

Question 11

1. Glycogen branching enzyme, because its absence prevents the formation of a proper, dense glycogen structure.
2. Liver glycogen phosphorylase (Hers' disease), because the inability to break down glycogen leads directly to hypoglycemia.
3. Glucose-6-phosphatase (von Gierke's disease), because its absence traps glucose-6-phosphate in the liver. (correct answer)
4. Debranching enzyme (Cori's disease), because its absence leads to the accumulation of abnormally structured glycogen.

Explanation: A deficiency in glucose-6-phosphatase (G6Pase) prevents the liver from releasing free glucose into the blood, causing severe fasting hypoglycemia. The resulting accumulation of glucose-6-phosphate allosterically activates glycogen synthase, leading to massive glycogen storage (hepatomegaly), and also shunts excess G6P into glycolysis, producing excess pyruvate and lactate (lactic acidosis). The other deficiencies do not account for all three symptoms; for example, a phosphorylase deficiency wouldn't cause significant lactic acidosis, and branching/debranching enzyme defects would alter glycogen structure.

Question 12

1. Unbranched, linear chains of glucose similar to amylose due to failed branching.
2. Highly branched molecules with numerous single glucose residues remaining at the α-1,6 branch points. (correct answer)
3. Normal glycogen structure but in vastly excessive quantities due to failed degradation.
4. Glycogen molecules with unusually long, unbranched outer chains due to impaired trimming.

Explanation: Glycogen phosphorylase stops four residues from a branch point. The transferase activity of the debranching enzyme moves three of these residues to a nearby chain. This leaves a single glucose attached by an α-1,6 bond. The amylo-α-1,6-glucosidase activity is required to cleave this bond. If this activity is missing, degradation halts at this point, resulting in an accumulation of glycogen with many single-glucose stubs at the former branch points (a type of limit dextrin).

Question 13

1. PKA directly phosphorylates and activates glycogen phosphorylase, while also directly phosphorylating and inactivating glycogen synthase.
2. PKA activates phosphorylase kinase, which activates glycogen phosphorylase; PKA also directly phosphorylates and inactivates glycogen synthase. (correct answer)
3. PKA activates protein phosphatase 1 (PP1), which dephosphorylates key enzymes to stimulate glycogenolysis.
4. PKA phosphorylates UDP-glucose pyrophosphorylase to inhibit the production of the substrate for glycogen synthase.

Explanation: PKA orchestrates reciprocal regulation. It does not directly phosphorylate glycogen phosphorylase. Instead, it phosphorylates and activates another enzyme, phosphorylase kinase. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase (stimulating breakdown). Simultaneously, PKA directly phosphorylates glycogen synthase, which inactivates it (inhibiting synthesis). This ensures a coordinated response.

Question 14

1. The formation of UDP-glucose is the primary rate-limiting step, allowing for precise control over glycogen metabolism.
2. The cleavage of the high-energy phosphoester bond in UDP-glucose makes the subsequent transfer of the glucosyl unit to glycogen exergonic. (correct answer)
3. The attachment of UDP is required to correctly position the glucose molecule within the active site of glycogen synthase for catalysis.
4. The pyrophosphate released during UDP-glucose formation is a potent allosteric activator of the glycogen synthase enzyme.

Explanation: The formation of a glycosidic bond is an energetically unfavorable process. By 'activating' glucose as UDP-glucose, the cell links it via a high-energy bond. The subsequent cleavage of this bond during the glycogen synthase reaction releases free energy (ΔG < 0), which drives the formation of the glycosidic bond, making the overall process of glycogen chain elongation thermodynamically favorable. UDP is an excellent leaving group in this context.

Question 15

1. Abnormally low blood lactate levels despite signs of muscle fatigue and cramping. (correct answer)
2. Markedly elevated blood lactate levels due to the high demand for ATP.
3. Severe hypoglycemia due to the inability of muscle glycogen to buffer blood glucose.
4. Elevated levels of free glucose in the muscle tissue due to a metabolic backup.

Explanation: When you encounter questions about glycogen storage diseases, focus on the specific enzymatic defect and trace its metabolic consequences through the affected pathways. McArdle disease involves a deficiency in muscle glycogen phosphorylase, the enzyme that breaks down glycogen into glucose-1-phosphate for glycolysis. During vigorous anaerobic exercise, muscles normally rely heavily on glycogen breakdown to fuel ATP production through glycolysis, which produces lactate as an end product. In McArdle disease, muscles cannot access their glycogen stores effectively. This creates a metabolic bottleneck: the muscle desperately needs glucose for energy but cannot break down its primary stored fuel source. The muscle becomes fatigued and cramps due to inadequate ATP production, but paradoxically produces little lactate because glycolysis is severely limited by the lack of glucose substrate. This explains why option A is correct - you see the clinical signs of energy deficit (fatigue and cramping) without the expected biochemical marker of anaerobic metabolism (elevated lactate). Option B is wrong because lactate levels are actually decreased, not elevated, due to impaired glycolysis. Option C incorrectly suggests muscle glycogen normally buffers blood glucose - muscle glycogen is metabolically separate from blood glucose regulation and cannot be released into circulation. Option D is incorrect because glucose levels in muscle would be low, not high, since the cells cannot generate glucose-1-phosphate from glycogen. Remember: in glycogen storage diseases, always consider what happens both upstream and downstream of the blocked enzyme to predict the full clinical picture.

Question 16

1. Increased glucose uptake from blood with normal lactate production to compensate for impaired glycogen breakdown
2. Rapid depletion of muscle ATP and phosphocreatine stores due to inability to mobilize stored muscle glycogen for glycolysis (correct answer)
3. Enhanced fatty acid oxidation with increased oxygen consumption to meet energy demands through aerobic metabolism
4. Activation of gluconeogenesis from muscle amino acids to provide glucose for local energy production within muscle fibers

Explanation: McArdle disease involves deficiency of muscle glycogen phosphorylase, preventing breakdown of muscle glycogen. During early exercise, muscles normally rely heavily on glycogen breakdown for rapid ATP production through glycolysis. Without this pathway, ATP and phosphocreatine stores deplete rapidly since fatty acid oxidation is too slow to meet immediate high energy demands. Choice A is incorrect because increased glucose uptake cannot fully compensate for the loss of the large glycogen store, and lactate production would actually be impaired. Choice C is incorrect because fatty acid oxidation is too slow for immediate energy needs in early exercise. Choice D is incorrect because muscle gluconeogenesis is not a significant source of glucose for local muscle metabolism.

Question 17

1. Glucagon receptors become desensitized, leading to decreased cAMP levels and reduced phosphorylase kinase activation over time
2. Progressive depletion of hepatic glycogen stores reduces substrate availability for phosphorylase despite continued enzyme activation (correct answer)
3. Increased cortisol during fasting competitively inhibits glucagon signaling through overlapping receptor pathways in hepatocytes
4. Accumulation of glucose-6-phosphate from gluconeogenesis provides negative feedback inhibition of glycogen phosphorylase activity

Explanation: Even with maximal enzyme activation, glycogen breakdown must eventually slow as glycogen stores become depleted. Hepatic glycogen stores are finite and can be substantially depleted within 12-18 hours of fasting. Phosphorylase activity depends on both enzyme activation state AND substrate availability. Choice A is incorrect because glucagon signaling remains effective during prolonged fasting, though some desensitization may occur, it's not the primary limitation. Choice C is incorrect because cortisol actually enhances rather than inhibits gluconeogenic capacity. Choice D is incorrect because glucose-6-phosphate inhibits glycogen synthase, not phosphorylase, and G6P levels would be kept low by glucose-6-phosphatase activity during glucose output.

Question 18

1. H89 cannot cross the cell membrane effectively, so protein kinase A continues to phosphorylate phosphorylase kinase intracellularly
2. Calcium released from sarcoplasmic reticulum during epinephrine treatment continues to activate phosphorylase kinase through calmodulin binding
3. Epinephrine activates both PKA and calcium signaling pathways, and phosphorylase kinase remains active through its calcium-calmodulin regulatory mechanism (correct answer)
4. Protein phosphatase 1 is inhibited by phosphorylated inhibitor-1, preventing dephosphorylation of phosphorylase kinase despite PKA inhibition

Explanation: Phosphorylase kinase can be activated by two mechanisms: phosphorylation by PKA (through cAMP) and calcium-calmodulin binding. Epinephrine in muscle activates both pathways - cAMP/PKA signaling and calcium release. Even when PKA is inhibited, elevated calcium levels continue to activate phosphorylase kinase through the calcium-calmodulin mechanism. Choice A is incorrect because H89 is membrane permeable and effectively inhibits PKA. Choice B is partially correct about calcium but misses that this is a normal dual regulatory mechanism. Choice D is incorrect because even though inhibitor-1 may be phosphorylated, this doesn't explain sustained activation when PKA is blocked - the calcium mechanism does.

Question 19

1. PP1 has different substrate specificities in liver versus adipose tissue, where hormone-sensitive lipase is primarily located
2. Hormone-sensitive lipase is dephosphorylated by protein phosphatase 2A rather than PP1, so insulin's activation of PP1 doesn't affect it
3. PP1 activity is compartmentalized through targeting subunits that direct it to glycogen particles and fatty acid synthesis complexes but not lipolysis enzymes (correct answer)
4. Hormone-sensitive lipase requires a different insulin signaling pathway involving PI3K/Akt rather than the PP1 activation mechanism

Explanation: PP1 activity is directed to specific substrates through targeting subunits that localize the phosphatase to particular cellular locations and enzyme complexes. In liver, PP1 is targeted to glycogen particles (affecting glycogen synthase and phosphorylase) and lipogenic enzyme complexes (affecting acetyl-CoA carboxylase) but not to hormone-sensitive lipase. This allows selective regulation of different metabolic pathways. Choice A is incorrect because the question refers to liver cells, not tissue differences. Choice B is incorrect because while other phosphatases may be involved, the primary issue is PP1 targeting. Choice D is incorrect because insulin does regulate hormone-sensitive lipase, but through different mechanisms than direct PP1 dephosphorylation.

Question 20

1. Fluoride directly inhibits glycogen phosphorylase by binding to the active site and preventing substrate access
2. Fluoride blocks glucose-6-phosphatase activity, leading to glucose-6-phosphate buildup that provides negative feedback on glycogen breakdown
3. Fluoride forms complexes with essential metal ions required for phosphorylase catalytic activity, rendering the enzyme inactive
4. Fluoride inhibits enolase in glycolysis, causing glucose-6-phosphate accumulation that allosterically inhibits glycogen phosphorylase (correct answer)

Explanation: When you encounter questions about metabolic regulation, focus on how pathways interconnect and how metabolites from one pathway can regulate another through allosteric effects. Fluoride's primary metabolic effect occurs in glycolysis, where it inhibits enolase, the enzyme that converts 2-phosphoglycerate to phosphoenolpyruvate. When enolase is blocked, glycolytic intermediates accumulate upstream, particularly glucose-6-phosphate. This glucose-6-phosphate buildup creates a powerful allosteric inhibition of glycogen phosphorylase, effectively shutting down glycogen breakdown even though the enzyme remains in its active, phosphorylated form. This explains why glycogen breakdown stops despite the phosphorylase appearing structurally active. Option A is incorrect because fluoride doesn't directly bind to glycogen phosphorylase's active site. Option B misidentifies the enzyme affected—while glucose-6-phosphatase is involved in glucose metabolism, fluoride's primary target is enolase, not glucose-6-phosphatase. Option C suggests fluoride chelates metal ions needed by phosphorylase, but glycogen phosphorylase doesn't require metal cofactors for its catalytic mechanism, and this wouldn't explain the specific pattern observed. The key insight is recognizing that fluoride's inhibition of enolase creates a metabolic traffic jam, backing up glucose-6-phosphate, which then allosterically inhibits the very pathway (glycogenolysis) that would normally produce more glucose-6-phosphate. Remember: metabolic pathways are interconnected networks. When studying enzyme inhibitors, always consider both direct effects and downstream consequences that might regulate other pathways through allosteric mechanisms.